Caribou Biosciences, Inc.
CRBU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$149,105 | -$102,070 | -$99,421 | -$66,923 |
| Dep. & Amort. | $3,927 | $3,525 | $3,641 | $984 |
| Deferred Tax | $0 | $0 | -$95 | $0 |
| Stock-Based Comp. | $16,706 | $13,750 | $0 | $3,449 |
| Change in WC | -$5,114 | -$7,318 | -$4,109 | $29,067 |
| Other Non-Cash | -$4,614 | -$1,178 | $9,018 | $904 |
| Operating Cash Flow | -$138,200 | -$93,291 | -$90,966 | -$32,519 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,880 | -$11,613 | -$6,454 | -$2,121 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$304,393 | -$394,758 | -$339,063 | -$173,276 |
| Inv. Sales/Matur. | $397,492 | $338,188 | $252,868 | $0 |
| Other Inv. Act. | -$1,612 | $0 | -$600 | -$1,000 |
| Investing Cash Flow | $86,607 | -$68,183 | -$93,249 | -$176,397 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1,031 |
| Stock Issued | $15,192 | $152,720 | $2,133 | $321,020 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,532 | $1,578 | $0 | $111,378 |
| Financing Cash Flow | $16,724 | $154,298 | $2,133 | $433,429 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$34,869 | -$7,176 | -$182,082 | $224,513 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $51,208 | $58,384 | $240,420 | $15,953 |
| End Cash | $16,339 | $51,208 | $58,338 | $240,466 |
| Free Cash Flow | -$144,705 | -$104,904 | -$97,420 | -$35,640 |